SurePace Powered Walker User for Cerebral Palsy

Phase-Based Progress Estimates
University of Virginia Motion Analysis and Motor Performance Lab, Charlottesville, VA
Cerebral Palsy
SurePace Powered Walker User - Device
Any Age
All Sexes
What conditions do you have?

Study Summary

The research is towards an advanced control and computer learning strategy that will intelligently drive a powered walker for people with walking disabilities. The aim of the control strategy is to provide powered assistance that optimally reduces the metabolic cost of walking. The goal of the proposed intelligent walker is to reduce the workload of walking, keeping this population walking longer, providing critical exercise, continued muscle development and improved quality of life.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Five minutes

Five minutes
Metabolic Cost (oxygen consumption)

Trial Safety

Trial Design

1 Treatment Group

SurePace Powered Walker User
1 of 1
Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: SurePace Powered Walker User · No Placebo Group · N/A

SurePace Powered Walker User
Experimental Group · 1 Intervention: SurePace Powered Walker User · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: five minutes
Closest Location: University of Virginia Motion Analysis and Motor Performance Lab · Charlottesville, VA
N/AFirst Recorded Clinical Trial
1 TrialsResearching Cerebral Palsy
0 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have no walking disabilities.
You have not had any surgeries in the last 6 months.
You understand and follow commands.
You have spastic CP.\n
You are ages 5-25.
You are able to walk without the use of a walker.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.